Tenderwize
Retour à la recherche

Open-house rebate agreement for Timolol

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 461 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Timolol, ATC S01ED01

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

Contract documents must be submitted in the DTVP communication area, not in the offer area; using the wrong channel cou...

The latest contract conclusion date is 2027-12-03, and monthly cut-off rules apply for next-month start dates.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Non-exclusive rebate agreement for Timolol, ATC S01ED01.
  • Supply of pharmaceutical products under an open-house model.
Afficher le résumé complet

This is an open-house pharmaceutical supply arrangement for Timolol (ATC S01ED01) led by AOK Bayern. It is not a competitive award procedure in the usual sense: the notice states that all interested pharmaceutical companies meeting the stated eligibility condition may conclude identical, non-negotiable, non-exclusive rebate agreements. The contract period runs from 2026-02-01 to 2028-01-31, with contract entry possible until 2027-12-03. Submission is via DTVP electronic communication area or by paper originals in duplicate; German language is required, and non-German documents need a German translation.

Risques

Contract documents must be submitted in the DTVP communication area, not in the offer area; using the wrong channel cou...

The latest contract conclusion date is 2027-12-03, and monthly cut-off rules apply for next-month start dates.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical company.

Administrative

  • Signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
  • Signed contract and completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be submitted.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Timolol

Open-house supply arrangement for the pharmaceutical product Timolol, ATC S01ED01. The lot scope is a non-exclusive rebate agreement for interested pharmaceutical companies; the notice says the contract terms are fixed and not individually negotiable. Place of performance is Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jan 2026 - Jan 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Dec 03, 2027

Détails de la procédure

Date de publication
14 Dec 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
829522-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30